Nurse who tried Mounjaro becomes first confirmed UK death linked to NHS weight loss jabs
After them came along Mounjaro which, as well as mimicking GLP-1 ... research suggests that without sustained lifestyle changes users tend to lose muscle mass before putting fat back on.
What UK’s first Mounjaro-linked death means for future of weight-loss jabs
Susan McGowan took two doses of tirzepatide, sold under the brand name Mounjaro, before she died on 4 September
First death connected to weight loss jabs approved by NHS as nurse dies after two doses
Susan McGowan, 58, is thought to have become the first fatality connected to Mounjaro, the "King Kong" of weight loss jabs
Influencers hold Mounjaro weight loss jab party - miles from where 'nurse' died taking it
An influencer, known as Heather, has organised a party celebrating weight loss jab tirzepatide, close to where NHS worker Susan McGowan took two doses of the drug, who later died
Mounjaro v Wegovy: Inside the race to reveal the best weight-loss jab
A trial, targeted at people living with obesity from Britain to Puerto Rico, is the first head-to-head comparison of the weight-loss effects of the two blockbuster slimming jabs
'Bubbly and kind' nurse dies in first confirmed UK death linked to NHS weight loss jabs
Susan McGowan, 58, was given two injections of the new generation of drugs being rolled out on the NHS which make people feel full sooner before her death in September
Nurse becomes first UK death linked to NHS-approved weight-loss jab Mounjaro
A weight drug recently legalised in the UK contributed to the death of a 58-year-old nurse, according to a new report.
Nurse’s death linked to approved weight-loss drug
The death of a nurse from North Lanarkshire has been linked to the use of a weight-loss drug recently approved for use on the NHS. Susan McGowan, 58, took two low-dose injections of tirzepatide, known under the brand name Mounjaro,
tyla3d
Mounjaro explained as Adam Lambert speaks out on drastic weight loss and why he stopped taking Ozempic
Mounjaro explained as Adam Lambert speaks out on Instagram live about his drastic weight loss and why he stopped taking ...
CNBC on MSN11d
Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still disappointed
Eli Lilly's blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro posted weaker-than-expected sales for the ...
Lilly’s Mounjaro, Zepbound drugs see strong demand. So why did sales disappoint?
Eli Lilly’s stock heads for biggest selloff in more than three years after sales of anti-obesity drugs Mounjaro and Zepbound ...
Eli Lilly stock tumbles 10% after drug giant misses estimates and slashes profit guidance
Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase ...
Eli Lilly stock sinks after Q3 earnings miss Wall Street expectations
Eli Lilly's stock valuation sank by $100 billion Wednesday morning after the pharma giant reported third quarter earnings.